Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preoperative Chemosensitivity Testing as Predictor of Treatment Benefit in Adjuvant Stage III Colon Cancer: PePiTA Trial

NCT00994864 is registered in ClinicalTrials.gov with Jules Bordet Institute as lead sponsor.

NCT NCT00994864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00994864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preoperative Chemosensitivity Testing as Predictor of Treatment Benefit in Adjuvant Stage III Colon Cancer: PePiTA Trial
Lead sponsor
Jules Bordet Institute
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2009
Completion date
December 31, 2022
Enrollment
235 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer